PART I Item 1. Bu siness. In this Annual Report on Form 10-K, we, our, us, Annexon and the Company refer to Annexon, Inc. and its consolidated subsidiary. Annexon, Annexon, Inc., the Annexon logo and other trade names, trademarks or service marks of Annexon are the property of Annexon, Inc. This report contains references to our trademarks and to trademarks belonging to other entities. Trade names, trademarks and service marks of other companies appearing in this report are the property of their...
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001193125-26-131782 | EDGAR | 83K words |
| 2025-03-03 | 2024-12-31 | 0000950170-25-030849 | EDGAR | — |
| 2024-03-26 | 2023-12-31 | 0000950170-24-036408 | EDGAR | — |
| 2023-03-06 | 2022-12-31 | 0000950170-23-006232 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001564590-22-008044 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001564590-21-015262 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001193125-25-274240 | EDGAR | 57K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108869 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0000950170-25-069200 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127057 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095401 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058659 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0000950170-23-062913 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039054 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018797 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021509 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0000950170-22-015560 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0000950170-22-008494 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001193125-26-131746 | EDGAR | 3K words |
| 2026-02-17 | 0001193125-26-054695 | EDGAR | — |
| 2026-01-14 | 0001193125-26-012918 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009740 | EDGAR | — |
| 2025-11-14 | 0001193125-25-283191 | EDGAR | — |
| 2025-11-10 | 0001193125-25-274220 | EDGAR | — |
| 2025-08-14 | 0000950170-25-108859 | EDGAR | — |
| 2025-06-25 | 0001193125-25-147005 | EDGAR | — |
| 2025-06-09 | 0001193125-25-137810 | EDGAR | — |
| 2025-05-12 | 0000950170-25-069156 | EDGAR | — |
109 total filings indexed. 81 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001528115 |
| Ticker | ANNX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.annexonbio.com |
| Listed | 2020-07-24 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report